Integrated care for inflammatory bowel disease patients in the Netherlands with the novel telemedicine tool myIBDcoach: a randomized controled trial

Completed

• Conditions: Crohn's disease; ulcerative colitis; 10017969

• Registration Number: NL-OMON41419
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-07-17
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 909

Inclusion Criteria

- diagnosis confirmed Crohn's disease or ulcerative colitis
- age between 18 and 75
- Patient has/can use a computer or tabloid or smart phone with a connection to the internet

Exclusion Criteria

- Patients who do not speek Dutch
- Patient discharged from the hospital within 2 week prior to baseline

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoints:<br /><br>Difference between study arms REGARDING:<br /><br>* Visits to the outpatient clinic<br /><br>* Patient satisfaction with IBD health care</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints:<br /><br>Difference between study arms REGARDING:<br /><br>* Complications (hospital admissions, duration of hospital admission, need for<br /><br>steroid use)<br /><br>* Compliance<br /><br>* Patient reported quality of care<br /><br>* Medication adherence<br /><br>* Self-efficacy<br /><br>* Quality of life<br /><br>* Knowledge about the disease and treatment<br /><br>* Disease activity: amount of flares, mean relapse duration<br /><br>* Consumption of healthcare<br /><br>* Smoking</p><br>